Literature DB >> 3876879

Epidermal growth factor stimulates the growth of A431 tumors in athymic mice.

E Ginsburg, B K Vonderhaar.   

Abstract

Growth of the human epidermoid carcinoma cell line A431 in vitro is stimulated by low concentrations of epidermal growth factor (EGF; 0.1-10 pM) and inhibited by high concentrations (0.1-10 nM). This cell also grows as a solid tumor in female athymic mice. Sustained high levels of EGF in vivo can be achieved by the administration of testosterone to female mice via a cholesterol-based pellet inserted subcutaneously. This chronic elevation of EGF levels (serum concentration = 90 ng/ml), however, does not affect growth of the tumor. In contrast, low levels of the growth factor (0.5 micrograms/g body wt by injection 5 times/week; serum concentration = 8.25 ng/ml) stimulate growth of the tumor. These data suggest that the mechanism(s) involved in the inhibition of A431 cell growth by EGF in vitro does not function in vivo and the physiologically significant effect of EGF in vivo is growth promotion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876879     DOI: 10.1016/0304-3835(85)90069-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice.

Authors:  Y Murayama
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

Review 3.  Signaling and drug sensitivity.

Authors:  R D Christen; S Isonishi; J A Jones; A P Jekunen; D K Hom; R Kröning; D P Gately; F B Thiebaut; G Los; S B Howell
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

4.  The role of recombinant epidermal growth factor and serotonin in the stimulation of tumor growth in a SCCHN xenograft model.

Authors:  Christin Geissler; Markus Hambek; Anne Eckardt; Christoph Arnoldner; Marc Diensthuber; Timo Stöver; Jens Wagenblast
Journal:  Oncol Rep       Date:  2012-07-06       Impact factor: 3.906

5.  Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.

Authors:  B Long; B M McKibben; M Lynch; H W van den Berg
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

6.  The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study.

Authors:  Hyun-Cheol Kang; Seung-Do Ahn; Doo-Ho Choi; Min Kyu Kang; Woong-Ki Chung; Hong-Gyun Wu
Journal:  Radiat Oncol J       Date:  2014-09-30

7.  Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.

Authors:  Z Fan; Y Lu; X Wu; A DeBlasio; A Koff; J Mendelsohn
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

8.  Contribution of host-derived growth factors to in vivo growth of a transplantable murine mammary carcinoma.

Authors:  D E Davies; S Farmer; J White; P V Senior; S L Warnes; P Alexander
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

9.  Effect of endogenous and exogenous EGF on the growth of EGF receptor-hyperproducing human squamous cell carcinoma implanted in nude mice.

Authors:  Y Kitagawa; M Ueda; N Ando; S Ozawa; M Kitajima
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.